Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses

US11034732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11034732-B2
Application numberUS-201916409317-A
CountryUS
Kind codeB2
Filing dateMay 10, 2019
Priority dateMay 10, 2017
Publication dateJun 15, 2021
Grant dateJun 15, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).

First claim

Opening claim text (preview).

What is claimed is: 1. An adeno-associated virus (AAV) capsid polypeptide comprising an amino acid sequence having at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 3. 2. The AAV capsid polypeptide of claim 1 , having the amino acid sequence of SEQ ID NO:3. 3. The AAV capsid polypeptide of claim 1 , encoded by the nucleic acid sequence of SEQ ID NO: 4. 4. A virus particle comprising the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 5. The virus particle of claim 4 , further comprising a transgene. 6. A nucleic acid molecule comprising a nucleic acid sequence encoding the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 7. The nucleic acid molecule of claim 6 , having the nucleic acid sequence of SEQ ID NO: 4. 8. The nucleic acid molecule of claim 6 , encoding the amino acid sequence of SEQ ID NO: 3. 9. A vector comprising the nucleic acid molecule of claim 6 . 10. A host cell comprising the nucleic acid molecule of claim 6 . 11. The host cell of claim 10 , wherein the host cell is a packaging cell. 12. A packaging cell comprising a nucleic acid molecule encoding the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 13. The packaging cell of claim 12 , wherein the packaging cell lacks an assembly activating protein (AAP). 14. An AAV capsid polypeptide comprising the amino acid sequence of SEQ ID NO:1 comprising amino acid substitutions K163T, A2065, K478R, L481V, V520M, T528S, L586N, A592Q, P593A, N599H, S600N, and A603V.

Assignees

Inventors

Classifications

  • viral genome or elements thereof as genetic vector · CPC title

  • C07K14/005Primary

    from viruses · CPC title

  • Viral vectors · CPC title

  • New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title

  • C07K14/015Primary

    Parvoviridae, e.g. feline panleukopenia virus, human parvovirus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11034732B2 cover?
Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
Who is the assignee on this patent?
Massachusetts Eye & Ear Infirmary, Schepens Eye Res Inst
What technology area does this patent fall under?
Primary CPC classification C07K14/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).